Oklahoma Medicaid and tirzepatide
Zepbound for weight loss: no. Prior authorization for moderate to severe sleep apnea in adults with obesity. Mounjaro for weight loss: no; for type 2 diabetes Oklahoma Medicaid must cover it. Read from Oklahoma Health Care Authority documents Nov 6, 2026.
In 2025 Oklahoma Medicaid paid for 13,923 tirzepatide prescriptions (Mounjaro, Zepbound), 17% of its GLP-1 prescriptions and 30th of the 50 states and DC. It reimbursed $14.6 million before rebates, $1,046 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 13,923 | $14.6 million | $1,046 |
| Zepbound | 0 | $0 | $NaN |
Oklahoma plans and prescribing rules
Blue Cross and Blue Shield of Oklahoma. Blue Cross and Blue Shield of Oklahoma treats GLP-1 weight-management coverage as an optional choice for employer groups. From November 1, 2026, self-funded groups with Prime Therapeutics that cover these drugs can set a $150 member cost share for up to a 30-day supply.
Tirzepatide in the states around Oklahoma
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Oklahoma | 17 | $69/moWellmedr | 13,923 | Medicaid Zepbound: No |
| Arkansas | 15 | $69/moWellmedr | 1,873 | Medicaid Zepbound: No |
| Colorado | 17 | $69/moWellmedr | 32,029 | Medicaid Zepbound: No |
| Kansas | 17 | $69/moWellmedr | 34,414 | Medicaid Zepbound: Yes |
| Missouri | 16 | $69/moWellmedr | 127,722 | Medicaid Zepbound: Yes |
| New Mexico | 17 | $69/moWellmedr | 18,921 | Medicaid Zepbound: No |
| Texas | 17 | $69/moWellmedr | 49,092 | Medicaid Zepbound: No |



